Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊ Π°ΡΠ΅ΡΠΈΠ»Ρ ΠΎΠ»ΠΈΠ½ΡΡΡΠ΅ΡΠ°Π·Π΅ ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ² ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
ΠΡΡΠΊΠ°Π·Π°Π½ΠΎ ΠΏΡΠ΅Π΄ΠΏΠΎΠ»ΠΎΠΆΠ΅Π½ΠΈΠ΅ ΠΎ ΡΡΡΠ΅ΡΡΠ²ΠΎΠ²Π°Π½ΠΈΠΈ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π΄ΠΈΠ°Π΄Ρ Ser99-His35, ΠΏΠΎΠ΄ΡΠ²Π΅ΡΠΆΠ΄Π΅Π½Π½ΠΎΠ΅ ΠΊΠΎΠΌΠΏΡΡΡΠ΅ΡΠ½ΡΠΌ ΠΌΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ. ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠΉ ΡΡΠ΅Ρ ΠΌΠ΅ΡΠ½ΠΎΠΉ ΠΌΠΎΠ΄Π΅Π»ΠΈ 9Π8 Ρ Π΄Π°Π½Π½ΡΠΌΠΈ ΡΠ΅Π½ΡΠ³Π΅Π½ΠΎ-ΡΡΡΡΠΊΡΡΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΡΡΡΠ΅ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½ΡΠΈΡΠ΅Π»Π° 17Π8. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ Π°ΠΊΡΠΈΠ²Π½ΡΠ΅ ΡΠ΅Π½ΡΡΡ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°Π΅ΠΌΡΡ Π°Π½ΡΠΈΡΠ΅Π» ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ ΡΠΎΠ²ΠΏΠ°Π΄Π°ΡΡ. ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ, ΡΡΠΎ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² MA 9Π8… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
- Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- ΠΡΠ΄Π΅ΡΠΆΠΊΠ°
- ΠΠΈΡΠ΅ΡΠ°ΡΡΡΠ°
- ΠΡΡΠ³ΠΈΠ΅ ΡΠ°Π±ΠΎΡΡ
- ΠΠΎΠΌΠΎΡΡ Π² Π½Π°ΠΏΠΈΡΠ°Π½ΠΈΠΈ
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΏΠΈΡΠΎΠΊ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ
- ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- 1. ΠΡΠΊΡΡΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π°
- 1. 1. ΠΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π°, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΠΈΠΌΠΌΡΠ½ΠΈΠ·Π°ΡΠΈΠ΅ΠΉ Π°Π½Π°Π»ΠΎΠ³Π°ΠΌΠΈ ΠΏΠ΅ΡΠ΅Ρ ΠΎΠ΄Π½ΡΡ ΡΠΎΡΡΠΎΡΠ½ΠΈΠΉ
- 1. 2. ΠΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π», ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠΈΡ ΠΊΠΎΡΠ°ΠΊΡΠΎΡΡ Π² ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠ΅ΠΌ ΡΠ΅Π½ΡΡΠ΅
- 1. 3. ΠΠ²ΠΎΠ΄ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΎΠΉ Π³ΡΡΠΏΠΏΡ Π² ΡΠ²ΡΠ·ΡΠ²Π°ΡΡΠΈΠΉ ΡΠ΅Π½ΡΡ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Ρ ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΌΠΎΠ΄ΠΈΡΠΈΠΊΠ°ΡΠΈΠΈ ΠΈΠ»ΠΈ ΡΠ°ΠΉΡ Π½Π°ΠΏΡΠ°Π²Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΠΌΡΡΠ°Π³Π΅Π½Π΅Π·Π°
- 1. 4. Π‘ΠΎΠ·Π΄Π°Π½ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π» Π΄Π»Ρ ΠΊΠ°ΡΠ°Π»ΠΈΠ·Π° ΡΠ½Π΅ΡΠ³Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ Π½Π΅Π²ΡΠ³ΠΎΠ΄Π½ΡΡ ΠΏΡΠ΅Π²ΡΠ°ΡΠ΅Π½ΠΈΠΉ
- 2. ΠΡΠΈΡΠΎΠ΄Π½ΡΠ΅ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π°
- 3. ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π°
- 3. 1. ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° ΠΊ ΡΠ΅ΡΠ΅ΠΏΡΠΎΡΠ°ΠΌ
- 3. 2. ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π²Π°ΠΊΡΠΈΠ½Ρ
- 3. 3. Π‘ΡΡΡΠΊΡΡΡΠ½ΡΠ΅ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ Π°Π½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΡ Π°Π½ΡΠΈΡΠ΅Π»
- 3. 4. ΠΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π°
- 3. 4. 1. ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°Π½ΡΠΈΡΠ΅Π»ΠΎ 9G4H9, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠ΅Π΅ Ρ-Π»Π°ΠΊΡΠ°ΠΌΠ°Π·Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ
- 3. 4. 2. ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°Π½ΡΠΈΡΠ΅Π»ΠΎ 9Π8, ΠΎΠ±Π»Π°Π΄Π°ΡΡΠ΅Π΅ Π°ΡΠ΅ΡΠΈΠ»Ρ
ΠΎΠ»ΠΈΠ½ΡΡΡΠ΅ΡΠ°Π·Π½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡΡ
- 3. 4. 2. 1. Π‘ΡΡΠΎΠ΅Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΠ΅Π½ΡΡΠ° ΠΈ ΡΠ²ΠΎΠΉΡΡΠ²Π° Π°ΡΠ΅ΡΠΈΠ»Ρ ΠΎΠ»ΠΈΠ½ΡΡΡΠ΅ΡΠ°Π·Ρ
- 3. 4. 2. 2. ΠΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°Π½ΡΠΈΡΠ΅Π»ΠΎ ΠΠ
- 3. 4. 2. 3. ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°Π½ΡΠΈΡΠ΅Π»ΠΎ 9Π
- 4. 1. ΠΡΡΠ΅ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°Π½ΡΠΈΡΠ΅Π»ΠΎ 17Π
- 4. 2. ΠΡΡΠ΅ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠ΅ Π°Π½ΡΠΈΡΠ΅Π»ΠΎ CNJ206 ΠΈ ΡΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ Π΅Π³ΠΎ Ρ ΡΡΡΠ΅ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌ Π°Π½ΡΠΈΡΠ΅Π»ΠΎΠΌ 17Π
- 4. 3. Π‘ΡΠ°Π²Π½Π΅Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΡΡ ΡΠ΅Π½ΡΡΠΎΠ² ΡΡΠ΅Ρ ΡΡΡΠ΅ΡΠΎΠ»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ Π°Π½ΡΠΈΡΠ΅Π», ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΡ Π½Π° ΠΎΠ΄ΠΈΠ½ Π°Π½Π°Π»ΠΎΠ³ ΠΏΠ΅ΡΠ΅Ρ ΠΎΠ΄Π½ΠΎΠ³ΠΎ ΡΠΎΡΡΠΎΡΠ½ΠΈΡ ΡΠ΅Π°ΠΊΡΠΈΠΈ
- 3. 1. ΠΠ»ΠΎΠ½ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ Π°Π½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π
- 3. 2. Π€ΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½Π°Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Fab-ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠ° Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π
- 4. 1. Π‘ΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠΉ ΡΡΡΡΠΊΡΡΡΡ Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π
- 4. 2. ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π8 Ρ ΡΠΎΡΡΠΎΠ½Π°ΡΠ½ΡΠΌΠΈ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠ°ΠΌΠΈ ΡΡΡΠ΅ΡΠ°Π·
- 4. 3. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΏΠ΅ΠΏΡΠΈΠ΄Π½ΡΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π
- 4. 4. ΠΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ Π°ΠΊΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΡΠ΅Π½ΡΡΠ° Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π8 — 78 ΠΠ°ΡΠ΅ΡΠΈΠ°Π»Ρ ΠΈ ΠΌΠ΅ΡΠΎΠ΄Ρ
- 2. 1. ΠΠ°ΡΠ°Π±ΠΎΡΠΊΠ° ΠΌΠΎΠ½ΠΎΠΊΠ»ΠΎΠ½Π°Π»ΡΠ½ΡΡ Π°Π½ΡΠΈΡΠ΅Π»
- 2. 2. ΠΠ΅Π»Ρ-ΡΠΈΠ»ΡΡΡΠ°ΡΠΈΡ
- 2. 3. ΠΠΎΠ½ΠΎΠΎΠ±ΠΌΠ΅Π½Π½Π°Ρ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΡ
- 2. 4. ΠΡΡΠΈΠ½Π½Π°Ρ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΡ
- 2. 5. ΠΠ΅Π½Π°ΡΡΡΠΈΡΡΡΡΠΈΠΉ ΡΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅Π· Π² ΠΠΠΠ
- 2. 6. ΠΠΌΠΌΡΠ½ΠΎΠ±Π»ΠΎΡΡΠΈΠ½Π³
- 2. 7. ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ ΠΈΠ΄ΠΈΠΎΡΠΈΠΏ-Π°Π½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΏΠΎΠ²Π΅ΡΡ Π½ΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΏΠ»Π°Π·ΠΌΠΎΠ½Π½ΠΎΠ³ΠΎ ΡΠ΅Π·ΠΎΠ½Π°Π½ΡΠ°
- 2. 8. ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Fab-ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠ° Π² Π. Col
- 2. 9. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡΡΠ΅ΠΌΡΡ ΡΡΠ°Π³ΠΌΠ΅Π½ΡΠΎΠ² ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΌΠ΅ΡΠ°Π»Π»-Ρ Π΅Π»Π°ΡΠ½ΠΎΠΉ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΠΈ
- 2. 10. ΠΠΌΠΏΠ»ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΠΉ ΡΠ΅ΡΠΌΠ΅Π½Ρ-Π·Π°Π²ΠΈΡΠΈΠΌΡΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΡΠΎΡΠ±ΡΠΈΠΎΠ½Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ·
- 2. 11. ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ»Π»ΠΌΠ°Π½Π°
- 2. 12. ΠΠΎΠ΄Π³ΠΎΡΠΎΠ²ΠΊΠ° Π±Π΅Π»ΠΊΠΎΠ² ΠΊ Π³ΠΈΠ΄ΡΠΎΠ»ΠΈΠ·Ρ
- 2. 13. Π’ΡΠΈΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π³ΠΈΠ΄ΡΠΎΠ»ΠΈΠ· Π±Π΅Π»ΠΊΠ° Π΄Π»Ρ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°
- 2. 14. ΠΡΠΈΠ³ΠΎΡΠΎΠ²Π»Π΅Π½ΠΈΠ΅ ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² Π΄Π»Ρ ΠΌΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π°
- 2. 15. ΠΠ°ΡΡ-ΡΠΏΠ΅ΠΊΡΡΠΎΠΌΠ΅ΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ MALDI
- 2. 16. ΠΠ·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π° 9Π8 ΡΠΎ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ ΡΠΎΡΡΠΎΠ½Π°ΡΠ½ΡΠΌΠΈ ΠΈΠ½Π³ΠΈΠ±ΠΈΡΠΎΡΠ°ΠΌΠΈ ΡΠ΅ΡΠΈΠ½ΠΎΠ²ΡΡ Π³ΠΈΠ΄ΡΠΎΠ»Π°Π·
- 2. 17. ΠΡΠ΄Π΅Π»Π΅Π½ΠΈΠ΅ ΠΌΠΎΠ΄ΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ ΠΏΠ΅ΠΏΡΠΈΠ΄Π° ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π°ΡΡΠΈΠ½Π½ΠΎΠΉ Π²ΡΡΠ΅ΡΠ½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠΉ Ρ ΡΠΎΠΌΠ°ΡΠΎΠ³ΡΠ°ΡΠΈΠΈ
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Pauling L. (1948) Chemical achi evement and hope for the future. Am. Sci. 36, 51−58.
- Jencks W. P. (1969) Catalysis in chemistry and enzymology. Mc Graw-Hill, NY, 1969, 836 p.
- Kohler G., Milstein C. (1975) Continuous cultures of fused cells screening antibody of predefined specificity. Nature, 256, 495−497.
- Jerne N. Π. (1974) Toward a network theory of the immune system. Ann. Immunol, 125, 373−378.
- Raso. W., Stollar B. D. (1975) The antibody-enzyme analogy. Biochemistry, 14, 591−599.
- Kohen F., Kim J. Π., Barnard G., Lindner H. R. (1980) Antibody-enhanced hydrolysis of steroid esters. Biochim. Biophys. Acta., 629, 328−337.
- Kohen F., Kim J. Π., Lindner H. R., Eshhar Z., Green B. (1980) Monoclonal immunoglobulin G augments hydrolysis of an ester of the homologous hapten: an esterase-like activity of the antibody-containing site? FEBS Lett., Ill, 427−431.
- Pollack S. J., Jacobs J. W., Schultz P. G. (1986) Selective chemical catalysis by an antibody. Science, 234, 1570−1573.
- Tramontano A., Janda K. D., Lerner R. A. (1986) Catalytic antibodies . Science, 234, 1566−1570.
- Tramontano A. Ammann A. A., Lerner R. A. (1988) Antibody catalysis approaching the activity of enzymes. J. Am. Chem. Soc., 110, 2282−2286.
- Shokat Π. M., Schultz P. G. (1990) Catalytic Antibodies. Ann. Rev. Immun., 8, 335−363.
- Schultz P. G. (1988) The interplay between chemistry and biology in the design of enzymatic catalysts. Science, 240, 426−433.
- Napper A. D., Bencovic S. J., Tramontano A., Lerner R. (1987) A stereospecific cyclisation catalyzed by and antibody. Science, 237, 1041−1043.
- Jackson D. Y., Jacobs H. W., Sugasawara R., Reich S. H., Bartlett P. A., Schultz P.G. (1988) An Antibody-catalyzed Claisen Rearrangement. J. Am. Chem. Soc., 110, 4941−4942.
- Hilvert D., Nared K. D. (1988) Stereospecific Claisen Rearragement Catalyzed by an Antibody. J. Am. Chem. Soc., 110, 5593−5594.
- Bencovic S. J., Napper A. D., Lerner R. A. (1988) Catalysis of a Stereospecific Bimolecular Amide Synthesis by an Antibody. Proc. Natl. Acad. Sci. USA. 85, 5355−5358.
- Hilvert D., Hill K. W., Nared K. D., Auditor M. Π’. M. (1989) Antibody Catalysis ofaDiels-Alder Reaction. J. Am. Chem. Soc., Ill, 9261−9262.
- Braisted A. C., Schultz P.G. (1990) An Antibody-catalyzed Bimolecular Diels-Alder Reaction . J. Am. Chem. Soc., 112, 7430−7431.
- Romesberg F. E., Spiller Π., Schultz P. G., Stevens R. C. (1998) Immunological Origins of Binding and Catalysis in a Diels-Alderase Antibody. Science, 279, 1929−1933.
- Xu J., Deng Q., Chen J., Houk K. N., Bartek J., Hilvert D., Wilson I. A. (1999) Evolution of shape complementarity and catalytic efficiency from a primordial antibody template. Science 286(5448), 2345−2348.
- Braisted A. C., Schultz P. G. (1994) An antibody catalyzed oxy-Cope rearragement. J. Am. Chem. Soc., 116, 2211−2212.
- E. C. Mundorff, M. A. Hanson, A. Varvak, H. Ulrich, P. G. Schultz, R. C. Stevens. (2000) Conformational effects in biological catalysis: an antibody-catalyzed oxy-cope rearrangement. Biochemistry, 39(4), 627−632.
- Quinn D. M. (1987) Acetylcholinesterase: Enzyme structure, reaction dynamics and virtual transition states. Chem. Rev., 87, 955−979.
- Pollack S. J., Jacobs J. W., Schultz P. G. (1986) Selective Chemical Catalysis by an Antibody. Science, 234, 1570−1573.
- Tawfik D. S., Lindner Π. Π., Chap R., Eshhar Z. Green B. S. (1997) Efficient and Selective p-nitrophenyl-ester-hydrolysing Antibodies Elicited by a p-nitrophenyl Phosphonate hapten. Eur. J. Biochem. 244, 619−626.
- Suzuki H., Mukouyama E. Π., Wada C., Kawamura-Konishi Y., Wada Y., Ono M. (1998) A Catalytic antibody that Accelerates the Hydrolysis of carbonate esters. Prediction of the binding-site structure of the substrate. J. Protein Chem. 17, 273−278.
- Janda K. D., Schloeder D., Benkovic S. J., Lerner R. A. (1988) Induction of an antibody that catalyzes the hydrolysis of an amide bond. Science, 241, 1188−1191.
- Blackburn G. M., Kang A. S., Kingsbury G. A., Burton D. R. (1989) Catalytic antibodies. J. Biochem., 262, 381−390.
- Π. Π. Thayer, Π. Π. Olender, A. S. Arvai, Π‘. Π. Koike, I. L. Canestrelli, J. D. Stewart, S. J. Benkovic, E. D. Getzoff, V. A. Roberts. (1999) Structural basis for amide hydrolysis catalyzed by the 43C9 antibody. JMolBiol, 291(2), 329−345.
- Janda K. D., Weinhouse M. I., Schloeder D. M., Lerner R. A. (1990) Bait and Switch strategy for obtaining catalytic antibodies with acyl transfer capabilities. J. Am. Chem. Soc., 112, 1274−1275.
- Wentworth P., Liu Y., Wentworth A. D., Fan P., Foley M. J., Janda K. D. (1998) A bait and switch strategy generates catalytic antibodies for phosphodiester hydrolysis. Proc. Natl. Acad. Sci. USA, 95, 5971−5975.
- Iverson B. L., Lemer R. A. (1989) Sequence specific peptide cleavage catalyzed by an antibody. Science, 243, 1184−1188.
- Hsieh L. C., Stephans J. C., Schultz P. G. (1994) An efficient antibody catalysed oxygenation reaction. J. Am. Chem. Soc., 116, 2167−2168.
- Hsieh L. C., Yonkovich S., Kochersperger L., Schultz P. G. (1993) Controlling chemical reactivity with antibodies. Science, 260, 337−339.
- Baldwin E., Schultz P. G. (1989) Generation of a catalytic antibody by site-directed mutagenesis. Science, 245, 1104−1107.
- Pollack S. J., Nakayama G. R., Schultz P. G. (1988) Introduction of nucleophiles and spectroscopic probes into combining sites. Science, 242, 1038−1040.
- Iverson B. L., Iverson S. A., Roberts V. A., Getzoff E. D., Tainer J. A., Benkovic S. J., Lerner R. A. (1990) Metalloantibodies. Science, 249, 659−662.
- Stewart J. D., Roberts V. A., Crowder M. W., Getzoff E. D., Benkovic S. J. (1994) Creation of a novel biosensor for Zn(II). J. Am. Chem. Soc., 116, 415−416.
- Ding L., Liu Z., Zhu Z., Luo G., Zhao D., Ni J. (1998) Biochemical characterisation of selenium-containing antibody as a cytosolic glutathione peroxidase mimic. Biochemistry, 332, 251−255.
- Fletcher M. C., Kuderova A., Cygler M., Lee J. S. (1998) Creation of ribonuclease abzyme through site-directed mutagenesis. Nat. Biotechnol., 161, 1065−1067.
- Janda K. D., Schloeder D., Lerner R. A. (1993) Antibody catalysis of a disfavored chemical transformation. Science, 259,490−493.
- Gruber K, Zhou B, Houk KN, Lerner RA, Shevlin CG, Wilson I A. (1999) Structural basis for antibody catalysis of a disfavored ring closure reaction. Biochemistry, 38(22), 7062−7074.
- Shabat D., Itzhaky H., Reymond J.-L., Keinan E. (1995) Antibody catalysis of a reaction otherwise strongly disfavored in water. Nature, 374,143−146.
- Sinha S.C., Keinan E. (1995) Catalytic antibodies in organic synthesis. Asymmetric synthesis of (-)-a-multistriatin. J. Am. Chem. Soc. 117, 3653−3654.
- Miyashita H., Karaki Y., Kikuchi M., Fujii I. (1993) Prodrug activation via catalytic antibodies. Proc. Natl. Acad. Sci. USA, 90, 5337−5340.
- Landry D.W., Zhao K., Yang G.X., Glickman M., Georgiadis T.M. (1993) Antibody-catalyzed degradation of cocaine. Science, 259, 1899−1901.
- De Prada P., Wigner G., Landry D. W. (2000)Application of artificial enzymes to the problem of cocaine. Ann. NY Acad. Sci., 909, 159−169.
- Stewart J.D., Benkovich S.J. (1995) Transition-state stabilization as a measure of the efficiency of antibody catalysis. Nature, 375, 388−391.
- Hilvert D. (2000) Critical analysis of antibody catalysis. Annual Rev. Biochem., 69,751−793.
- Paul S., Voile D.J., Beach C.M., Johnson D.R., Powell M.J., Massey R.J. (1989) Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody. Science, 244, 1158−1162.
- Sun M., Gao Q.S., Li L., Paul S. (1994) Proteolytic activity of an antibody light chain. J. Immunol., 153, 5121−5126.
- Gao Q.S., Sun M., Tyutyulkova S., Webster D., Rees A., Tramontano A., Massey R.J., Paul S. (1994) Molecular cloning of a proteolytic antibody light chain. J. Biol. Chem., 269, 32 389- 32 393.
- Gao Q. S. and Paul S. (1995) Site-directed mutagenesis of proteolytic antibody light chain. J. Mol. Biol., 253, 658−664.
- Sun M. and Paul S. (1997) Altered cleavage site preference of a proteolytic antibody light chain induced by denaturation. FEBSLett., 407, 289−290.
- ΠΠΎΠ»ΠΎΠ»ΠΎΠ±ΠΎΠ² Π. Π., Π¨ΡΡΡΠ΅Ρ Π. Π., ΠΠ²Π°ΡΡΠΊ Π©. Π., ΠΠ°Π±ΠΈΠ±ΠΎΠ² Π. Π. (1991) ΠΠ½ΡΠΈΠΈΠ΄ΠΈΠΎΡΠΈΠΏΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΊΠ°ΡΠ°Π»ΠΈΡΠΈΡΠ΅ΡΠΊΠΈ Π°ΠΊΡΠΈΠ²Π½ΡΠ΅ Π°Π½ΡΠΈΡΠ΅Π»Π°. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ ΠΠΈΠΎΠ»ΠΎΠ³ΠΈΡ, 25, 593−602.
- Shuster Π. Π., Gololobov G. V., Kvashuk Π. A., Bogomolova Π. Π., Smirnov I. V., Gabibov A. G. (1992) DNA-hydrolyzing autoantibodies. Science, 256, 665 667.
- Gabibov A. G., Gololobov G. V., Makarevich Π. I., Shourov D. V., Chernova E. A., Yadav R. P. (1994) DNA-hydrolyzing autoantibodies. Appl. Biochem. Biotechnol., 47, 293−303.
- Li L., Paul S., Tyutyulkova S., Kazatchkine M. D., Kaveru S. (1995) Catalytic activity of anti-thyroglobulin antibodies. J. Immunol., 154, 3328−3332.
- Rose N. R., Burec C. L. (2000) Autoantibodies to thyroglobulin in health and disease. Appl. Biochem. Biotechnol, 83(1−3), 245−251.
- Oudin J. and Michel M. (1963) Une nouvelle forme d’allotypie des globulines Ρ du serum de lapin, apparemment liee a la fonction et la specificite des anticorps. C. R. Acad. Sci., 257, 805−808.
- Pan Y., Yuhasz S. C., Amzel L. M. (1995) Anti-idiotypic antibodies: biological function and structural studies. FASEB J., 9, 43−49.
- Strosberg A. D. (1989) Interaction of anti-idiotypic antibodies with membrane receptors: practical considerations. Methods Enzymol., 178, 179−191.
- McNamara M. K., Ward R. E., Kohler H. (1984) Monoclonal idiotope vaccine against Streptpcpccus pmeumonie infection. Science, 226, 1325−1326.
- Kennedy R., Eichberg J., Lanford R., Dreesman G. (1986) Antiidiotype antibody vaccine for type Π viral hepatitis in chimpanzees. Science, 232, 220−223.
- Rimmelzwann G. F., Bunschoten E. J., Uytdehaag F. G. Π‘. M., Osterhaus A. D. M. E. (1989) Monoclonal anti-idiotypic antibody vaccines against poliovirus, canine parvovirus and rabies virus. Methods Enzymol, 178, 375−390.
- Fleuridor R., Zhong Z., Pirofski L. (1998) A human IgM monoclonal antibody prolongs survival of mice with lethalcryptococcosis. J. Infect. Dis., 178, 12 131 216.
- Tripathi P. Π., Qin H., Deng S., Xu C., Battacharya-Chatterejee M., Foon K. A., Chatterejee S. K. (1998) Antigen mimicry by an anti-idiotypic antibody single chain variable fragment. Mol. Immunol., 35, 853−863.
- Nisonoff A. (1991) Idiotypes: Concepts and applications. J. Immunol., 147, 24 292 438.
- Gaulton G. N., Green M. I. (1986) Idiotypic mimicry of biological receptors. Ann. Rev. Immunol., 4, 253−280.
- Bentley G. A., Boulot G., Riottot M. M., Poljak R. J. (1990) Three-dimesional structure of an idiotope-antiidioitope complex. Nature, 348, 254−257.
- Ban N., Escobar C., Garcia R., Hasel K., Day J., Greenwood A., McPherson A. (1994) Crystal structure of and anti-idiotype Fab-complex. Proc. Natl. Acad. Sci. USA, 911 604−1608.
- Garcia Π. C., Ronco P. M., Verroust P. J., Brunger Π. Π’., Amzel L. M. (1992) The three dimensional structure of an angiotensin II-Fab complex at 3 A: hormone recognition by an anti-idiotypic antibody. Science, 257, 502−507.
- Bronstein I. Π., Shuster A. M., Gololobov G. V., Gromova 1.1., Kvashuk O. A., Belostotskaya Π. M., Alekberova Z. S., Prokaeva Π’. Π., Gabibov A. G. (1992)
- DNA-specific antiidiotype antibodies in sera of patients with autoimmune diseases. FEBSLett., 314, 259−263.
- Avalle Π., Thomas D., Friboulet A. (1998) Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolysing P-lactams. FASEB J., 12, 10 551 060.
- Lamotte-Brasseur J., Dive G., Dideberg O., Charlier P., Frere J. M., Ghuysen J. M. (1991) Mechanism of acyl transfer by the class A serine p-lactamase of Streptomyces albus G. Biochem J., 279, 213−221.
- Avalle Π., Debat H., Friboulet F., Thomas D. (2000) Catalytic mechanism of an abzyme displaying a p-lactamase-like activity. Appl. Biochem. Bio techno!., 83, 163−169.
- Sussman J. L., Harel M., Frolow F., Oefner C., Goldman A., Torer L., Silman I. (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science, 253, 872−879.
- Rippol D. R., Faerman Π‘. H., Axelsen P. H., Silman I., Sussman J. L. (1993) An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase. Proc. Natl. Acad. Sci. USA, 90, 5128−5132.
- Radic Z., Reiner E., Taylor P. (1991) Role of the peripheral anionic site on acetylcholineserase: inhibition by substrates and coumarin derivatives. Mol. Pharmacol. 39, 98−104.
- Gibney G., Camp S., Dionne M., MacPhee-Quigney K., Taylor P. (1990) Mutagenesis of essential functional residues in acetylcholinesterase. Proc. Natl Acad. Sci. USA, 87, 7546−7550.
- Duval N. Bon S., Silman I., Sussman J., Massoulix J. (1992) Site-directed mutagenesis of active-site-related residues in Torpedo acetylcholinesterase. FEBS Lett., 309, 421−423.
- Gilson M. K., Straatsma T. P., McCammon J. A., Ripoll D. R., Faerman Π‘. H., Axelsen P. H., Silman I., Sussman J. L. (1994) Open «Back door» in a molecular dynamics simulation of acetylcholinesterase. Science, 263, 1276−1278.
- Bartolucci C., Perola E., Cellai L., Brufani M., lamba D. (1999) «Back door» opening implied by the crystal structure of a carbamoilated acetylcholineserase. Biochemistry, 38, 5714−5719.
- Fambrough D. M., Engel A.G., Rosenberry T. L. (1982) Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 79, 1078−1082.
- Sorensen K., Brodbek U., Rasmussen A. G., Norgaard-Pederson B. (1987) An inhibitory monoclonal antibody to human acetylcholinesterase. Biochem. Biophys. Acta, 912, 56−62.
- Joron L., Izadyar L., Friboulet A., Remy M. E., Pancino G., Roseto A., Thomas D. (1992) Antiidiotypic antibodies exibiting an acetylcholinesterase abzyme activity.
- Ellman G. L., Courtney K. D., Andres V., Featherstone R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol., 7, 88−95.
- Zhou W. G., Guo J., Huang W., Fletterick R. J., Scanlan T. S. (1994) Crystal structure of a catalytic antibody with a serine protease active site. Science, 265, 1059−1064.
- Charbonnier J. Π., Golinelli-Pimpaneau Π., Gigant Π., Tawfik D. S., Chap R., Schindler D. G., Kim S. H., Green B. S., Eshhar Z., Knossow M. (1997) Structural convergence in the active site of a family of catalytic antibodies. Science, 275, 1140−1142.
- Guo J., Huang W., Zhou G. W., Fletterick R. J., Scanlan T. S. (1995) Mechanistically different catalytic antibodies obtained from immunization with a single transition-state analog. Proc. Natl. Acad. Sci. USA, 92, 1694−1698.
- Patten P. A., Gray N. S., Yang P. L., Marks Π‘. Π., Wedemayer G. J., Boniface J. J, Stevens R. C., Schultz P. G. (1996) The immunological evolution of catalysis. Science, 111, 1086−1091.
- Laemmli U, Π. (1970) Cleavage of structural proteins during the assembly of the head off bacteriophage T4. Nature, 227, 680 -685.
- Brigham-Burke M., Edwards J.R., O’Shannessy D. J. (1992) Detection of receptor-ligand interaction using surface plasmon resonance: model studies employing the HIV-1 gpl20/CD4 interactions. Anal. Biochem., 205, 125−131.
- R. L. Rich, D. G. Myszka. (2000) Advances in surface plasmon resonance biosensor analysis. Curr Opin Biotechnol. 11(1), 54−61.
- U. Jonsson, L. Fagerstam, B. Ivarsson, B. Johnsson, R. Karlsson, et al,. (1991) Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Biotechniques 11(5), 620−627
- Kabat E. A., Wu Π’. Π’., Perry H. M., Gottesman K. S., Foeller C. Sequences of proteins of immunological interest. 1991. 5-th ed., Public health service, National Institute of Health, USA.
- Tramontano A., Ivanov Π., Gololobov G. V., Paul S. (2000) Inhibition and labeling of enzymes and abzymes by phosphonate diesters. Appl. Biochem. Biotechnol., 83, 233−243.
- Harlow E., Lane D. Antibodies: a Laboratory Manual. New York.: Cold Spring Harbor Laboratory, Cold Spring Harbor, 1988, 726.
- F. Hillenkamp, M. Karas. (1991) Mass spectrometry of peptides and proteins by matrix-assisted ultraviolet laser desorption/ionization. Methods Enzymol., 193, 280−295.
- R. A. Kohanski, M. D. Lane, (1990). Monovalent avidin affinity columns. Meth. Enzymol., 184, 194−200.
- M. C. Peitsch, (1996) ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem Soc Trans., 24 274−279.
- N. Guex and M. C. Peitsch, (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis., 18 27 142 723.
- Porath J, Carlsson J, Olsson I, Belfrage G. (1975) Metal chelate affinity chromatography, a new approach to protein fractionation. Nature, 258(5536) 598 599-Ibir.lOTLJ.vM, 1Π―26Π‘- Π!